Brochure More information from http://www.researchandmarkets.com/reports/3293052/

Richter Gedeon Nyrt. - Product Pipeline Review - 2015 Description:

Richter Gedeon Nyrt. - Product Pipeline Review - 2015 Summary This, ‘Richter Gedeon Nyrt. - Product Pipeline Review - 2015’, provides an overview of the Richter Gedeon Nyrt.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Richter Gedeon Nyrt.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in -class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Richter Gedeon Nyrt. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Richter Gedeon Nyrt.’s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Richter Gedeon Nyrt.’s pipeline products Reasons to buy - Evaluate Richter Gedeon Nyrt.’s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Richter Gedeon Nyrt. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Richter Gedeon Nyrt.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Richter Gedeon Nyrt. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Richter Gedeon Nyrt.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Richter Gedeon Nyrt. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues

Contents:

List of Tables List of Figures Richter Gedeon Nyrt. Snapshot Richter Gedeon Nyrt. Overview Key Information Key Facts Richter Gedeon Nyrt. - Research and Development Overview Key Therapeutic Areas Richter Gedeon Nyrt. - Pipeline Review Pipeline Products by Stage of Development Pipeline Products - Monotherapy Richter Gedeon Nyrt. - Pipeline Products Glance Richter Gedeon Nyrt. - Late Stage Pipeline Products Pre-Registration Products/Combination Treatment Modalities Phase III Products/Combination Treatment Modalities Richter Gedeon Nyrt. - Clinical Stage Pipeline Products Phase II Products/Combination Treatment Modalities Richter Gedeon Nyrt. - Early Stage Pipeline Products Preclinical Products/Combination Treatment Modalities Discovery Products/Combination Treatment Modalities Richter Gedeon Nyrt. - Unknown Stage Pipeline Products Unknown Products/Combination Treatment Modalities Richter Gedeon Nyrt. - Drug Profiles cariprazine Product Description Mechanism of Action R&D Progress pegfilgrastim Product Description Mechanism of Action R&D Progress Small Molecule for Undisclosed Indication Product Description Mechanism of Action R&D Progress rituximab biosimilar Product Description Mechanism of Action R&D Progress trastuzumab biosimilar Product Description Mechanism of Action R&D Progress teriparatide biosimilar Product Description Mechanism of Action R&D Progress Richter Gedeon Nyrt. - Pipeline Analysis Richter Gedeon Nyrt. - Pipeline Products by Target Richter Gedeon Nyrt. - Pipeline Products by Route of Administration Richter Gedeon Nyrt. - Pipeline Products by Molecule Type Richter Gedeon Nyrt. - Pipeline Products by Mechanism of Action Richter Gedeon Nyrt. - Recent Pipeline Updates Richter Gedeon Nyrt. - Dormant Projects Richter Gedeon Nyrt. - Discontinued Pipeline Products Discontinued Pipeline Product Profiles

radiprodil RGH-512 Richter Gedeon Nyrt. - Company Statement Richter Gedeon Nyrt. - Locations And Subsidiaries Head Office Other Locations & Subsidiaries Appendix Methodology Coverage Secondary Research Primary Research Expert Panel Validation Contact Us Disclaimer List of Tables Richter Gedeon Nyrt., Key Information Richter Gedeon Nyrt., Key Facts Richter Gedeon Nyrt. - Pipeline by Indication, 2015 Richter Gedeon Nyrt. - Pipeline by Stage of Development, 2015 Richter Gedeon Nyrt. - Monotherapy Products in Pipeline, 2015 Richter Gedeon Nyrt. - Pre-Registration, 2015 Richter Gedeon Nyrt. - Phase III, 2015 Richter Gedeon Nyrt. - Phase II, 2015 Richter Gedeon Nyrt. - Preclinical, 2015 Richter Gedeon Nyrt. - Discovery, 2015 Richter Gedeon Nyrt. - Unknown, 2015 Richter Gedeon Nyrt. - Pipeline by Target, 2015 Richter Gedeon Nyrt. - Pipeline by Route of Administration, 2015 Richter Gedeon Nyrt. - Pipeline by Molecule Type, 2015 Richter Gedeon Nyrt. - Pipeline Products by Mechanism of Action, 2015 Richter Gedeon Nyrt. - Recent Pipeline Updates, 2015 Richter Gedeon Nyrt. - Dormant Developmental Projects,2015 Richter Gedeon Nyrt. - Discontinued Pipeline Products, 2015 Richter Gedeon Nyrt., Other Locations Richter Gedeon Nyrt., Subsidiaries List of Figures Richter Gedeon Nyrt. - Pipeline by Top 10 Indication, 2015 Richter Gedeon Nyrt. - Pipeline by Stage of Development, 2015 Richter Gedeon Nyrt. - Monotherapy Products in Pipeline, 2015 Richter Gedeon Nyrt. - Pipeline by Top 10 Target, 2015 Richter Gedeon Nyrt. - Pipeline by Top 10 Route of Administration, 2015 Richter Gedeon Nyrt. - Pipeline by Top 10 Molecule Type, 2015 Richter Gedeon Nyrt. - Pipeline Products by Top 10 Mechanism of Action, 2015

Ordering:

Order Online - http://www.researchandmarkets.com/reports/3293052/ Order by Fax - using the form below Order by Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.

Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit http://www.researchandmarkets.com/contact/

Order Information Please verify that the product information is correct and select the format(s) you require. Product Name:

Richter Gedeon Nyrt. - Product Pipeline Review - 2015

Web Address:

http://www.researchandmarkets.com/reports/3293052/

Office Code:

SC

Product Formats Please select the product formats and quantity you require: Quantity Electronic (PDF) Single User:

USD 1500

Electronic (PDF) Site License:

USD 3000

Electronic (PDF) Enterprisewide:

USD 4500

* The price quoted above is only valid for 30 days. Please submit your order within that time frame to avail of this price as all prices are subject to change.

Contact Information Please enter all the information below in BLOCK CAPITALS Title: First Name:

Mr

Mrs

Dr

Miss Last Name:

Email Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)

Ms

Prof

Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card:

You will receive an email with a link to a secure webpage to enter your credit card details.

Pay by check:

Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland.

Pay by wire transfer:

Please transfer funds to: Account number

833 130 83

Sort code

98-53-30

Swift code

ULSBIE2D

IBAN number

IE78ULSB98533083313083

Bank Address

Ulster Bank, 27-35 Main Street, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World